Roll over, Darwin: How Google DeepMind's 'mind evolution' could enhance AI thinking
This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...
AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...
A Chinese startup just showed every American tech company how quickly it's catching up in AI
The Chinese startup DeepSeek has released a new AI reasoning model that appears to rival the abilities of a frontier model ...
MIT Technology Review1d
The second wave of AI coding is here
A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest ...
Google rushed to sell AI tools to Israel’s military after Hamas attack
The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...
Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
DeepMind’s new inference-time scaling technique improves planning accuracy in LLMs
With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.
Why AI Creatives Are Touting Google’s Veo 2 as Best Video Generation Model
AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...
The Next Web2d
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
Hosted on MSN1d
Google DeepMind COO on AI Regulation, Jobs, Trump
Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...
ReadWrite1d
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
NextBigFuture9h
Demis Hassabis Thinks Searching Knowledge Is Needed for Superintelligent AI
Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...